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Abstract
Nanoparticles affect the immune system as they may interact directly with immune cells
and activate them. However, it is possible that nanoparticles also interact with released
cytokines and immunologically active enzymes. To test this hypothesis, the activity of
myeloperoxidase released from activated neutrophils was measured in the presence of
nanoparticles with different chemistry and size. In high concentrations of nanoparticles,
myeloperoxidase activity is decreased whereas in low concentrations of nanoparticles the
activity is increased. The effect of the nanoparticles on myeloperoxidase is dependent on
the total protein concentration as low concentrations of bovine serum albumin together with
nanoparticles further increase the myeloperoxidase activity. The results herein show that
nanoparticles affect the immune response not only at the cellular level but also on released
immune effectors. In particular, they show that the nanoparticle effect on myeloperoxidase
activity in the neutrophil degranulation environment is the result of an intricate interplay
between the enzyme and protein concentrations in the environment and the available sur-
face area on the nanoparticle.
Introduction
The exposure to nanoparticles (NPs) in nature and in humans is expected to increase. NPs are
intentionally and unintentionally released into nature [1–3], potentially ending up in food
webs[4], waterways, and in the atmosphere, for example from combustion of diesel fuel. This
leads to exposure routes through food and inhalation. Their actual and potential use in medical
applications creates direct exposure to interstitial fluids, blood and airways in humans.
NPs may affect the immune response and immune cells in diverse ways [5,6] and have been
reported as immunosuppressor or immunostimulator. As an illustrative example, Fe2O3 NPs
(around 5 nm in diameter) can induce the production of pro-inflammatory cytokines in mice
which can trigger the recruitment of neutrophils [7]. Moreover, it has been shown in ovalbu-
min-sensitized mice treated with a single exposure of iron oxide Fe2O3 NPs, (around 120 nm
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in diameter) a marked attenuation of ovalbumin-specific T- and B-cell response [8]. Both of
these studies looked at particles of the same composition, but different size and thus different
curvature, indicating that besides composition size of the NPs is an important characteristic to
consider.
Leukocytes are recruited into inflammatory foci following gradients of chemoattractant
molecules that can be produced upon activation of the complement system, by bacterial patho-
gens or by stromal or tissue resident hematopoietic cells [9]. Release of active enzymes by acti-
vated immune cells is an important feature in mediating numerous immune processes that
include host defense against invading pathogens [10,11], autoimmune pathology [12], or other
inflammatory conditions [13,14]. Neutrophils are particularly important inflammatory cells as
they are promptly recruited from the vasculature when inflammation is started but can also
mediate the pathogenesis of chronic diseases such as cancer or autoimmunity [15]. In the
infected or other inflammatory microenvironments, activated neutrophils may produce reac-
tive oxygen intermediates or degranulate releasing lytic enzymes such as proteases (e.g. elas-
tase, gelatinase, etc.), or myeloperoxidase (MPO) [16]. MPO is an immunologically active
enzyme that catalyzes the oxidation and chlorination of macromolecules using hydrogen per-
oxide as a substrate to form hypochlorous acid adducts [17–20]. Granule enzymes may be
released to the extracellular space or become associated with neutrophil extracellular traps
(NETs) where they can interact with any macromolecules present such as pathogen membrane
proteins [21]. NPs present in the organism can then interact with the neutrophil exocytosed
proteins.
In a biological fluid, NPs bind proteins forming a protein corona [22,23]. The interaction
with the nanoparticle surface will affect protein structure and function [24–28]. The effect on
the protein is dependent on the surface chemistry and the curvature, i.e. the size of the nano-
particle [24,25,29]. Enzymatic activity is one protein function that has been demonstrated to
be influenced by NPs surfaces [27]. Factor XII in the blood coagulation is inhibited, activated,
or unaffected by negatively charged polystyrene NPs depending on their surface chemistry and
curvature [30]. The effect on Factor XII activity depends on the overall protein concentration
as crowded surfaces affect the binding of proteins. Possibly because the structural change and
orientation can be different depending on the available surface area. Consequently, the NPs
impact on enzyme can be different in low protein conditions, for example, using only purified
proteins compared to high protein concentrations as in blood. The influence on protein struc-
ture and function by nanoparticle surfaces suggests that NPs can affect the immune response
by activating immune cells or by interacting and affecting the released enzymes from the acti-
vated immune cells. Not only protein‘s interactions with NPs are immunologically important.
Other biomolecules such as lipopolysaccharide and glycan can, after absorption to the NP‘s
surface, modulate the immune response to themselves [31,32]
Here, we have studied MPO activity in the presence of NPs with different chemistry and
size. We used polystyrene NPs with sizes between 25 and 220 nm and with different surface
chemistry, sulfon (OSO3), carboxyl (COOH) and amine (NH2), Table 1. This set of NPs makes
it possible to compare the effects of size of particles with the same surface chemistry and the
effect of differently charged modifications on the surface on nanoparticles with the same size.
TiO2 was added as metal oxide particle with a different surface chemistry and dispersion stabil-
ity. The obtained results show that MPO activity is affected by the particle surface and by the
presence of other proteins. Bovine serum albumin (BSA) decreased the MPO activity in solu-
tion but together with particles BSA in low concentrations increased the MPO activity indicat-
ing that the interaction between MPO and the particles surface is different depending on the
available surface area.
Nanoparticle effect on neutrophil produced myeloperoxidase
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Material and experiments
Proteins, serum and nanoparticles
MPO was purchased from Abcam, UK, and was dissolved in PBS, 100 μg/ml, and frozen in ali-
quots. BSA was purchased from Sigma and dissolved in PBS 35 mg/ml and frozen in aliquots.
Cow serum was purchased from Sigma or Innovative Science, USA and fetal calf serum (FCS)
from Innovative Science, USA. Both sera were initially defrosted, heat inactivated at 56˚C for
30 min and frozen in aliquots. All polystyrene particles were purchased from Bangs Inc, USA,
and TiO2 particles, anatase phase, from PlasmaChem, Germany Cat Nr PL-TiO-5p-10gr.
Characterization of size of particles and nanoparticles/protein complexes
The dynamic light scattering of 100 μl samples in 96 well non-treated polystyrene Costar1
assay plate, Corning, USA, was obtained on a DynaPro platereader-II, Wyatt Technology,
USA, at 25˚C, with 20 seconds accession time, 10 accessions per sample. All samples were mea-
sured in triplicate. The size of used NPs was determined in H2O, PBS 1× (phosphate buffered
saline), RPMI medium, RPMI supplemented with 10% FCS and the obtained light scattering
data were analyzed using the cumulative mode assuming one population of particles. Differen-
tial centrifugal sedimentation (DCS) was performed on DC24000 disc centrifuge (CPS Instru-
ments, USA), with a linear 8–24% sucrose gradient at 23,677 RPM.
The sulfon (PS-OSO3) or carboxyl (PS-COOH) modified polystyrene NPs have similar size
in H2O, PBS, and RPMI medium, whereas the amine (PS-NH2) modified polystyrene and
TiO2 NPs increase in PBS, Table 1. The size of all polystyrene NPs increase in 10% FCS indi-
cating the formation of protein corona and/or aggregation. The size of TiO2 NPs at different
particle and cow serum concentrations are further analyzed below. The zeta potential is nega-
tive for the PS-COOH, PS-OSO3, and TiO2 in PBS, and positive or neutral for the PS-NH2,
Table A in S1 Appendix.
Cell culture and activation
Human peripheral blood was obtained from healthy donors. Experiments involving human
blood and cells have been approved by the Ethics committee of ICBAS (document 172/2016).
The study was conducted according to the principles expressed in the Declaration of Helsinki.
Written informed consent was obtained from all study participants. Neutrophils were
Table 1. Characteristics of the used nanoparticles.
Particles with manufacturers diameter (nm) Diameter (nm)1
H2O PBS Media
2 Medium2 + 10% FCS
PS-COOH (26) 30.5 ± 0.1 28.3 ± 0.3 28.4 ± 0.1 57.9 ± 0.5
PS-COOH (60) 65.4 ± 0.2 59.3 ± 0.4 58.2 ± 0.5 120 ± 1
PS-COOH (220) 211 ± 1 205 ± 1 205 ± 2 258 ± 3
PS-NH2 (5756) 49.5 ± 0.1 245 ± 7 52.7 ± 0.4 243 ± 2
PS-NH2 (120) 111 ± 1 161 ± 3 118 ± 1 142 ± 1
PS-OSO3 (25) 29.4 ± 0.2 27.7 ± 0.2 28.6 ± 0.2 71.8 ± 1.2
TiO2 (5) 403
3 6033 4 4
1Determined by DLS of 0,1 mg/ml nanoparticles
2RPMI
3Determined by DSC
4Not Determined.
https://doi.org/10.1371/journal.pone.0191445.t001
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separated by centrifugation using Histopaque-1119/1077 gradient, Sigma Aldrich. Cells
were washed with PBS containing 2 mM EDTA with at least 3 volumes of buffer. Remaining
erythrocytes where then lysed with an ACK solution (Ammonium-Chloride-Potassium) and
neutrophils washed again with PBS containing 2 mM EDTA. The neutrophil pellet was resus-
pended in RPMI-1640 medium supplemented with Penicillin (200 IU/ml) and Streptomycin
(200 g/ml), L-Glutamine (4 mM), β-mercaptoethanol (0,05 mM) (all from Sigma), and with
10% FCS, Biowest, France or without serum when mentioned. Cells were then seeded in
96-well round-bottom culture plates (Nunc, Denmark) at 106 cells per well. 40 ng/ml of phor-
bol myristate acetate (PMA, from Sigma Aldrich) was added to each well to induce the release
of MPO during 4h. The media and cells were pooled and centrifuged at 300 g for 10 min. The
supernatants of activated neutrophils were immediately used for activity assays or kept frozen
at -80˚C for further experiments.
MPO activity assay in cell supernatant
100 μl of supernatant of activated neutrophils or 1 μg MPO in 100 μl PBS, were mixed with NPs
in a concentration of 0,25 to 1 mg/ml and incubated at 37˚C for 30 min. 50 μl of this reaction
were then added to two different wells in a 96-well plate. Freshly prepared 0,03% H2O2 solution in
100 mM NaAcetate, pH 5.2 (100 μl per well) was added followed by the addition of 100 μl of tetra-
methylbenzidine (TMB) ready to use substrate (from Thermo fisher Scientific). The MPO activity
was measured by following the cleavage of TMB substrate changing color to blue (followed at
605nm wavelength) when H2O2 is reduced by MPO. The reaction was then monitored on a plate
reader on kinetic mode for 30 min with an O.D. measurement at 605 nm wavelength every 30 s.
In the competition experiments 1 μg MPO were mixed with BSA in 100 μl PBS. The final
BSA concentration was between 1 and 36 mg/ml. PS-COOH, 60 nm, NPs were added to a con-
centration of 0.1 mg/ml. PBS was added to control samples without NPs. The MPO activity
was measured as above.
Separation and characterization of bound and unbound MPO
The direct interaction between MPO and NPs was analyzed by mixing MPO and nanoparticles
in PBS, and after 1 hour incubation, separating unbound MPO from bound by centrifugation,
13000 g, for 30 to 60 min. Thereafter, the supernatant was analyzed for MPO activity (see
above). The MPO concentration was 1 μg/ml and the nanoparticle concentration 0,1 mg/ ml. In
another set of experiment, 1 mg NPs were mixed with 1 or 2 μg of MPO in a total volume of
21 μl PBS. After centrifugation, the presence of MPO in the supernatant was determined by 10%
SDS-PAGE electrophoresis. High Molecular Weight standard, NZYColour Protein Marker II
(nzytech, Lisbon, Portugal) was used to determine protein mass upon silver staining. In both
experiments, the formed pellet was not stable which made it difficult to wash and analyze it.
Band quantification was implemented with ImageJ software with the embedded gel analysis tool.
The interaction between MPO and NPs were further analyzed by loading the mixtures of
MPO and NPs or only MPO or only NPs on top of a stepwise sucrose gradient. The first layer
was 10% sucrose in PBS and the second layer 40% sucrose in 50:50 PBS and TMB. The MPO
NPs mixtures were centrifuged at 18000 rpm for 30 minutes. The NPs with or without MPO
are captured at the 40% sucrose layer containing TMB. The color reaction was photographed
after 1 h incubation.
Statistical analysis
Results are expressed as mean values ± standard deviation. Data were analyzed by one-way
ANOVA followed by Holm-Sidak’s multiple comparisons test. Data were considered
Nanoparticle effect on neutrophil produced myeloperoxidase
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significant at p<0.05. GraphPad Prism version 6.01 (GraphPad Software, SanDiego, CA, USA)
for Microsoft1 Windows was used for statistical analyses
Results and discussion
One of the challenges in nanotoxicology studies is the understanding of the direct impact of
nanoparticles in a complex environment. Studies focused on the effect of particles on protein
function could lead to the deciphering of the net impact of nanoparticles on biological
pathways.
MPO mediates resistance to infectious agents as it is involved in both intracellular and
extracellular [21,33] killing of a wide range of pathogenic agents such as bacteria, fungi or
viruses. As observed, naturally occurring, MPO mutations in human can induce [34] structural
modifications in this enzyme that could affect its activity. Thus, MPO may have implications
in host physiology and the immune response, highlighting the importance of this protein in
some disease conditions. Patients with low or non-active enzymes in phagocytic vacuoles will
be deficient in microbial killing and will develop recurrent and severe infections. For example,
low or totally absent activity in NADPH oxidase of phagocytes is responsible for a clinical con-
dition designated as chronic granulomatous disease [35]. NADPH oxidase produces superox-
ide free radical converted into hydrogen peroxide; MPO catalyze the production of
hypochlorous acid using hydrogen peroxide and chloride anion [36]. The effect of NPs on
MPO would mimic a chronic enzymopathy during these crucial steps of microbial killing.
First, neutrophils prepared from freshly collected blood were incubated in serum free
medium and activated by PMA to stimulate granule release and thereby the release of MPO.
The MPO activity was measured by following the cleavage of the chromogenic substrate
changing color (to blue) when hydrogen peroxide is reduced by MPO. The change of colour
was followed at 605 nm. The effect of NPs on the MPO activity was evaluated by adding differ-
ent amount of polystyrene NPs with different size, surface chemistry and charge, and TiO2
NPs to culture supernatants of PMA-stimulated neutrophils. (See NPs characteristics in
Table 1) As the MPO concentration in the culture supernatants is not known, we report the
effect of NPs on the MPO activity as the percentage of control (no added nanoparticles—100%
MPO activity). Fig 1A shows that negatively charged PS-COOH nanoparticles inhibit the
MPO activity. Although the particles are of different size and thereby exhibit very different
surface area at the same mass concentration, strong inhibition (more than 80%) is only seen at
0.1 mg/ml. Fig 1B shows the effect of PS-NH2 NPs on the secreted MPO activity. As for the
PS-COOH NPs, there is an inhibition at 0.1 mg/ml of NPs. Furthermore, there is no size
dependency of the inhibition. PS-OSO3 NPs and TiO2 particles, Fig 1C, also inhibit the MPO
activity at the highest concentration.
Many cell assays and toxicological tests are performed in medium containing fetal calf
serum (FCS), which makes the medium protein rich. As in the serum free experiment, the
MPO activity is inhibited by the polystyrene particles although an increase in concentration is
needed going from 0.1mg/ml to 1mg/ml, Fig 2. However, smaller particles inhibit the MPO
activity more than larger particles, most likely due to the larger surface area. In protein rich
conditions, a larger surface area is probably needed because other proteins compete with MPO
for the particle surface. Interestingly, at the lowest particle concentration tested the MPO activ-
ity is increased. Moreover, in the protein rich media the lowest concentration increases the
activity of the MPO (120% of control activity, without added NPs) while in protein poor
media 0.1mg of any NPs tested in this study was enough to decrease the activity of MPO by
80%. One of the NPs tested, TiO2, does not inhibit the activity. This may be due to aggregation
of TiO2 particles in protein rich environment effectively decreasing available surface area.
Nanoparticle effect on neutrophil produced myeloperoxidase
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Fig 1. The effect of nanoparticles on secreted MPO in serum free media. A- PS-COOH NPs; B- PS-NH2 NPs; C-
PS-OSO3 or TiO2 NPs, as indicated. The supernatants from activated neutrophils were analysed for MPO activity. The
results are reported as % of MPO activity in supernatants without added nanoparticles. The results are a mean of three
separate experiments each done in duplicate. (#)p< 0,05 compared to control without NPs.
https://doi.org/10.1371/journal.pone.0191445.g001
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Fig 2. The effect of nanoparticle on secreted MPO in protein rich media. A- PS-COOH NPs; B- PS-NH2 NPs; C-
PS-OSO3 or TiO2 NPs, as indicated. The supernatants from activated neutrophils were analyzed for MPO activity. The
results are reported as % of MPO activity in samples without added nanoparticles in protein rich media. The results are
a mean of three separate experiments each done in duplicates. p< 0,05 for all concentration of nanoparticles versus 0,1
Nanoparticle effect on neutrophil produced myeloperoxidase
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However, at low particle concentrations the MPO activity is increased just as for the polysty-
rene particles. The aggregation of TiO2 in PBS and PBS with 10% serum will depend on the
particle concentration. Fig 3 shows the size measured by differential sedimentation ultracentri-
fugation, at two different concentrations of TiO2 in PBS. Compared to in water the aggregate
size is larger and the size distribution broader. Both parameters increase when the TiO2 con-
centration increases. Adding 10% FCS further increase the aggregate size. These data show
that the aggregation of TiO2 is different in different concentrations and different ratios of pro-
tein and particles, which makes a concentration dependent effect of TiO2 in protein rich envi-
ronments difficult to evaluate.
In Fig 2, there is a clear difference between the effects of particles with different surface
chemistry. The 25 nm PS-OSO3 NPs inhibit the MPO activity, in presence of serum, more
than similar sized PS-COOH NPs. These particles both have Z-potential charge but their sur-
face chemistry differs. Differences in the extent PS-COOH and PS-OSO3 NPs affecting enzy-
matic activity have been reported before, such as on the proteolytic activity of coagulation
factors. Small PS-COOH NPs inhibit the coagulation whereas it is unaffected by PS-OSO3 NPs
[30,37]. The inhibitory effect is directly on Factor XII [30]. Another difference due to the sur-
face chemistry is seen when comparing the effect of 60 nm PS-COOH and 57 nm PS-NH2
NPs on MPO in serum as the amine modified PS-NH2 inhibitory effect on MPO activity is
stronger, Fig 2.
The above results suggest, that depending on the conditions MPO activity can be either
increased or decreased by the particle surface. As the conditions in the cell media are complex,
we wanted to study the effect on MPO in a controlled environment using purified protein. Fig
4 shows how the different particles at two different concentrations affect purified MPO activ-
ity. All PS-COOH nanoparticles increase the MPO activity in PBS without FCS proteins or
any other protein neutrophils secrete, that could interact with the NPs surface. The increase in
mg/ml, expect for enzyme activity in presence of TiO2 which is not significantly different for all TiO2 concentration

p<0.05 versus activity in presence of 220nm COOH NPs. #p<0.05 versus activity in presence of 120 nm NPs. ●
p<0.05 versus activity in presence of 26 nm, 60 nm, 220nm COOH NPs, 120 nm NH2 NPs and TiO2 NPs at 1, 0.5, 0.25
mg/ml.
https://doi.org/10.1371/journal.pone.0191445.g002
Fig 3. The size of TiO2 particles in PBS or PBS with 10% serum. The peak diameter is defined as the diameter value
where normalized absorbance is 1, and the half height peak width (H.h.p.w.) is defined as the difference between the
two points where normalized absorbance is equal to 0.5.
https://doi.org/10.1371/journal.pone.0191445.g003
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activity is most pronounced for the 220 nm PS-COOH NPs. In the same mass concentration,
the available surface area is lower for the 220 nm than for the 60 and 26 nm PS-COOH NPs.
This indicates that it is not only the available surface area that determines the effect on the
MPO but also the curvature. As higher concentrations of particles decreased the MPO activity
in the cell media, it would have been interesting to see how higher particle concentration affect
the activity of the purified enzyme. However, further increase of the particle concentration
induced aggregation, which makes the analyses of enzyme activity impossible. The 57 nm
PS-NH2 nanoparticle increase the MPO activity whereas the 120 nm decrease the activity. This
is not only due to available surface area as the surface area in 0.1 mg/ml 120 nm particles is
approximately the same as the surface area in 0.02 mg/ml 57 nm particles, indicating that the
curvature effect is opposite for the amine modified particles compared to the carboxyl modi-
fied particles. The TiO2 particles decrease the MPO activity. Interestingly, the decrease is more
pronounced in lower particle concentration, probably due to particle aggregation and reduced
available surface area.
The data show that MPO is affected by the NPs surface. A likely explanation is that there is
a direct interaction between MPO and particles. All NPs were tested for MPO binding by add-
ing MPO particles mixtures on top of a stepwise sucrose gradient. In the top sucrose is 10% in
PBS and the bottom 40% in PBS and TMB, the MPO substrate. After centrifugation the MPO
Fig 4. The effect of nanoparticles on purified MPO. Purified MPO in PBS was mixed with the different particles before the MPO
activity was measured. The results are reported as % of MPO activity in samples without added nanoparticles.  p< 0,05 versus
enzyme activity without NPs.
https://doi.org/10.1371/journal.pone.0191445.g004
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NPs complexes are trapped in the 40% sucrose, which contain TMB. The presence of MPO is
detected by the colour reaction. In this assay all NPs interacted with MPO, Figure A in S1
Appendix. Thereafter we used three additional approaches to confirm the interaction between
the 60 nm PS-COOH NPs and MPO. First, 2 μg or 1 μg MPO were mixed with 1 mg of 60 nm
PS-COOH particles. After incubation the protein/particle complexes were pelleted by centrifu-
gation and the presence of MPO in the supernatants detected by SDS-PAGE electrophoresis
(Fig 5). The MPO is depleted from the supernatant indicating that MPO interacts strongly
with the 60 nm PS-COOH NPs. Second, we mixed 1 μg/ml MPO with 0.5 or 0.05 mg/ml of 60
nm PS-COOH particles, in the same conditions used to study the effect of PS-COOH on MPO
Fig 5. Interactions between 60 nm PS-COOH NPs and MPO evaluated by SDS-PAGE. Lane 1: High Molecular Weight standard
(kDa), lane 2: 0.5 μg MPO, lane 3–6: supernatant after centrifugation of 2 μg MPO (lanes 3 and 5) or 1 μg (lanes 4 and 6) mixed
with 1 μl (1 mg) 60 nm PS-COOH (lanes 3 and 4) or with 1 μl H20 (lanes 5 and 6). Image J software was used to estimate the bands
intensity and is represented as relative intensity for each lane (or relative quantity for each lane taking the first lane equal to 0.5μg/
ml of MPO).
https://doi.org/10.1371/journal.pone.0191445.g005
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activity (see Figs 4 and 5). The mixtures were centrifuged and the MPO activity in the superna-
tants assessed. The activity in the supernatants is lower than in the control samples (Table 2)
again indicating that MPO is depleted from solution as the particles are pelleted. The activity is
higher in the samples with more particles. The explanation for this is that in both centrifuga-
tion assays the formed pellets are loose and MPO/particle complexes may still be in the super-
natant. As MPO activity is increased in the presence of particles, the effect of a small amount
of MPO can give a relatively large signal. Third, the size of 60 nm PS-COOH particles in the
presence of MPO was determined. The size of the 60 nm PS-COOH particles is similar with or
without MPO, Table 2, which shows that in this concentration range of MPO and particles, no
particle aggregation occurs.
Next, we wanted to investigate how the competition of other proteins affects the impact of
NPs on MPO activity. We chose to use 60 nm PS-COOH particles and purified bovine serum
albumin (BSA). BSA is the most abundant protein in FCS and cow serum, moreover, approxi-
mately half the protein mass is albumin in blood serum. Fig 6 shows how the activity of MPO
is affected by increasing BSA concentration with or without 60 nm PS-COOH particles. At
high BSA concentration, the MPO activity is decreased. With particles alone, the activity is as
before increased. In the presence of 1 and 3 mg/ml BSA, the activity is further increased and
reaches a maximum at 1 mg/ml. At high BSA concentrations, the particles effect seems to be
weakened. To confirm the presence of MPO on the particles we used the same stepwise
sucrose gradient as above. MPO together with different concentrations of BSA was mixed with
the 60 nm PS-COOH NPs and loaded on top of the gradient. After centrifugation and incuba-
tion, the blue color on top of the 40% sucrose layer indicates the presence of MPO. As can be
seen in Figure B in S1 Appendix, MPO is present on the NPs in BSA concentrations from 0 to
9 mg/ml. These results support previous data in protein rich cell media. There is an increased
activity of the MPO depending on the surface area and on the amount of the surrounding pro-
teins on the surface.
We have previously seen that small 26 nm PS-COOH NPs inhibit factor XII coagulation
activity whereas larger PS-COOH NPs increase the factor XII activity. The size threshold
seems to be around 60 nm for PS-COOH and somewhat smaller for silica and metallic parti-
cles. The MPO activity is not clearly affected by curvature in our experimental conditions and
the observed differences can be explained by differences in the exposed surface area.
However, two differences are seen that can be due to surface curvature. First, pure MPO is
further activated by the 220 nm PS-COOH than by the 26 and 60 nm PS-COOH although the
smaller particles present more surface area, indicating that a small surface curvature activates
MPO more than a large surface curvature. Second, the activity of pure MPO in the presence of
120 nm PS-NH2 NPs is lower when compared with 57 nm PS-NH2 NPs. This effect cannot be
explained by differences in surface and may reflect that larger particles with smaller surface
curvature activate MPO less or do not activate MPO at all. Interestingly, differences in surface
chemistry result in opposite effects of the surface curvature. This clearly shows that it is diffi-
cult to predict how particles of different material and size will affect enzyme activity and stress
Table 2. Size of the 60 nm PS-COOH nanoparticles with or without MPO and MPO activity after removal of particles by centrifugation.
[Particle] (mg/ml) Diameter (nm) Activity in supernatant
Without MPO With MPO (% of MPO activity)
0.5 58.8 ± 0.2 59.2 ± 0.7 43 ± 3
0.05 / / 14 ± 12
0.02 60.6 61.4 ± 0.2 /
https://doi.org/10.1371/journal.pone.0191445.t002
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the need of experimental evaluations. The effect on MPO activity by the studied NPs is com-
plex. It seems to be determined not only by the surface curvature and chemistry but also by an
intricate interplay between available surface and the presence and competition of other pro-
teins. Several polystyrene particles increase the activity of purified MPO. This can be explained
by a direct interaction between the enzyme and the particle surface that change the structure
or stabilize the MPO structure. This has been seen for several other proteins in the presence of
NPs [24,26,27,29,38].
Another explanation is that putative weak distant interactions between the enzyme and the
surface and between the substrate and the surface would increase the effective concentrations
and reduce the diffusion distances. A weak interaction between the substrate and the surface
will also increase the activity if the enzyme is directly bound to the surface. Evidently, MPO
interacts strongly with the PS-COOH NPs, which suggests that the interaction stabilizes the
enzyme and/or induces a favorable structure. We have no indications of interactions between
the substrate and the surface but it cannot be ruled out.
The particle coverage is important for enzyme activity. The activity of trypsin adsorbed to
copper sulfide NPs is unaffected at low surface coverage whereas high surface coverage lowers
Fig 6. The combined effect of bovine serum albumin alone and albumin with 60 nm PS-COOH on MPO activity. MPO
was mixed with different concentrations of BSA and thereafter with 60 nm PS-COOH before the MPO activity is measured.
The results are reported as % of MPO activity in samples without added BSA or nanoparticles. All activities in presence of NPs
with or without added BSA are significantly different from activity without BSA (p<0.05).
https://doi.org/10.1371/journal.pone.0191445.g006
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the activity [39]. The opposite situation was shown for pyrophosphatase, as the activity was low
at low enzyme coverage and high at high surface coverage [40]. The effect of surface coverage is
attributed to the structural changes in the enzyme after binding to the surface [39,40]. The effect
of NPs on MPO activity is likewise dependent on the total protein concentration as the presence
of FCS or BSA affected the enzyme activity. This can be explained by that the interaction of
MPO with the NPs is different if the surface area is partly covered by other proteins, which
thereby limit or change how MPO binds to the surface, Fig 7. The 60 nm PS-COOH NPs, on
their own, activate MPO. Adding BSA to the system at low concentrations increases the activa-
tion. At higher BSA concentrations, the activity is decreased. At low BSA concentrations, MPO
may still bind to the particle surface but due to limited space on the surface, the binding mecha-
nism is different compared to a situation where there is unlimited space to bind to. This leads to
a more activated MPO. At higher BSA concentrations, MPO may be exchanged by BSA, and
the inhibitory effect of BSA on MPO in solution is dominating.
Lowering the activity of the enzymes produced during the degranulation is one kind of
effect that NPs in this study can have on the oxidative metabolism of neutrophils. In another
perspective, the effect of NPs by enhancing the activity of the enzymes and overproduction of
reactive oxygen species may lead to autoimmune pathology as observed in many inflammatory
conditions [41]. NPs may affect the immune response in different ways [7]. For instance, acti-
vation of the complement system is a well-known effect of diverse NPs [42]. Our study shows
that NPs can have a direct impact on the activity of immune effector enzymes. This emphasizes
the need of further studies on the effects that NPs may have on enzymes mediating crucial bio-
logical pathways.
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Fig 7. Schematic representation of how MPO (green), particle surface and BSA (blue) concentration interplay to
define the activity level of MPO. (A) When purified MPO interacts with the particle surface its interaction modifies
the conformation of the protein, which increase enzyme activity. (B) At medium protein concentration the MPO
interaction with the surface is influenced by other proteins and is very active. (C) In high protein concentration media
the MPO has less access to the surface and is less active either because of less MPO is bound to the surface or that the
conformational change is less favorable in a crowded environment.
https://doi.org/10.1371/journal.pone.0191445.g007
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